Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC-ND 4.0BMC Urology

Impact of the modified Frailty Index-5 on treatment selection and prognosis in octogenarians with bladder cancer eligible for radical cystectomy: a single-center, retrospective study

  1. 1Department of Urology, Jichi Medical University Hospital, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498 Japan
  2. 2Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Abstract

Background: Developing treatment strategies for bladder cancer in octogenarians remains challenging owing to concerns regarding surgical invasiveness and the risk of undertreatment. We aimed to evaluate the effect of the modified Frailty Index-5 score on treatment selection and prognosis in this population.

Methods: We retrospectively analyzed 44 patients with bladder cancer aged ≥ 80 years who were candidates for radical cystectomy. The patients were stratified into three groups: robot-assisted radical cystectomy (n = 10), non-surgical treatment (n = 24), and observation (n = 10). The primary endpoint was treatment selection, and the secondary endpoint was overall survival.

Results: Multivariate analysis revealed that surgical selection was more strongly associated with the modified Frailty Index-5 status (odds ratio: 0.31) than with chronological age or sex, suggesting that frailty assessment might play a crucial role in clinical decision-making. Overall survival did not differ significantly among the groups (p = 0.11); however, the robot-assisted radical cystectomy group showed a trend toward improved survival compared with the non-surgical treatment (hazard ratio [HR] 4.93; p = 0.054) and observation (HR 2.43; p = 0.38) groups.

Conclusions: Robot-assisted radical cystectomy appears to be a safe and feasible treatment option for carefully selected octogenarian patients. The modified Frailty Index-5 may serve as a practical and objective tool to support treatment decision-making, helping avoid undue risk aversion based solely on chronological age.

Related

  1. Cytoreductive cystectomy combined with chemotherapy versus chemotherapy alone in the treatment of metastatic bladder cancer: A retrospective comparative study.
    Bogdan O Hrechko, Oleg Voylenko, Iurii Vitruk +4
    Central European journal of urologyPeer-reviewedCC BY-NC-SAFull textSurgery & anaesthesiaEurope PMC
  2. Age is the wrong axis: rethinking surgical selection for octogenarians with early-stage non-small cell lung cancer
    Vasiliki Androutsopoulou, Prokopis-Andreas Zotos, Dimitrios E. Magouliotis
    Frontiers in surgeryPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  3. Five-fraction stereotactic body radiotherapy for prostate cancer in octogenarians and nonagenarians: A single-institution retrospective cohort study
    Atsuto Katano, Hideomi Yamashita
    Oncology LettersPeer-reviewedLicence not statedFull textGeneral medicinePMC
  4. Impact of different follow-up methods on prognosis of diabetic foot patients after endovascular treatment: a multicenter retrospective cohort study.
    Dazhi Li, Jialong Li, Maoji Ying +3
    MHealthPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismEurope PMCPMC
  5. Impact of the COVID-19 pandemic on diagnosis, treatment, and prognosis of cervical, endometrial, and ovarian cancers: A retrospective cohort study based on the SEER database.
    Chunyan Tan, Huibo Dai, Xingya Liu +3
    MedicinePeer-reviewedCC BYFull textOncologyEurope PMC
BibTeX
@article{hoshina2026impact,
  title = {{Impact of the modified Frailty Index-5 on treatment selection and prognosis in octogenarians with bladder cancer eligible for radical cystectomy: a single-center, retrospective study}},
  author = {Hayato Hoshina and Toru Sugihara and Masayuki Kurokawa and Ei-ichiro Takaoka and Haruki Kume and Tetsuya Fujimura},
  journal = {BMC Urology},
  year = {2026},
  month = aug,
  doi = {10.1186/s12894-026-02316-w},
  url = {https://doi.org/10.1186/s12894-026-02316-w},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Impact of the modified Frailty Index-5 on treatment selection and prognosis in octogenarians with bladder cancer eligible for radical cystectomy: a single-center, retrospective study
AU  - Hayato Hoshina
AU  - Toru Sugihara
AU  - Masayuki Kurokawa
AU  - Ei-ichiro Takaoka
AU  - Haruki Kume
AU  - Tetsuya Fujimura
PY  - 2026
DA  - 2026/08/18
JO  - BMC Urology
DO  - 10.1186/s12894-026-02316-w
UR  - https://doi.org/10.1186/s12894-026-02316-w
AB  - Background: Developing treatment strategies for bladder cancer in octogenarians remains challenging owing to concerns regarding surgical invasiveness and the risk of undertreatment. We aimed to evaluate the effect of the modified Frailty Index-5 score on treatment selection and prognosis in this population.  Methods: We retrospectively analyzed 44 patients with bladder cancer aged ≥ 80 years who were candidates for radical cystectomy. The patients were stratified into three groups: robot-assisted radical cystectomy (n = 10), non-surgical treatment (n = 24), and observation (n = 10). The primary endpoint was treatment selection, and the secondary endpoint was overall survival.  Results: Multivariate analysis revealed that surgical selection was more strongly associated with the modified Frailty Index-5 status (odds ratio: 0.31) than with chronological age or sex, suggesting that frailty assessment might play a crucial role in clinical decision-making. Overall survival did not differ significantly among the groups (p = 0.11); however, the robot-assisted radical cystectomy group showed a trend toward improved survival compared with the non-surgical treatment (hazard ratio [HR] 4.93; p = 0.054) and observation (HR 2.43; p = 0.38) groups.  Conclusions: Robot-assisted radical cystectomy appears to be a safe and feasible treatment option for carefully selected octogenarian patients. The modified Frailty Index-5 may serve as a practical and objective tool to support treatment decision-making, helping avoid undue risk aversion based solely on chronological age.
SN  - 1471-2490
ER  -